The American Academy of Neurology had its annual meeting recently, where the newest in research is presented with the hope of better treatments. At this year's meeting, we heard a lot about updates of clinical trials we are all becoming familiar with:
Rituximab - the monoclonal antibody directed against B cells. You will remember that... Read more
At our latest monthly MS Town Hall meeting, our excellent nurse practitioner discussed health insurance and how to get it and to remember to not leave a lapse. We had a visitor from England who related to us the different issues facing patients in England and she dispelled the myth that things are exponentially better across the... Read more
I was asked to comment on Modafinil (Provigil®). It was originally approved by the Food and Drug Administration (FDA) in 1998 for the treatment of excessive daytime sleepiness associated with narcolepsy, and since then has gained FDA-approval for the treatment of excessive sleepiness associated with Obstructive Sleep Apnea, Hypoventilation... Read more
As some of you know, I went to Washington DC as part of Neurology on the Hill with the American Academy of Neurology (AAN). They sponsor a two day event where neurologists from all over the country (all of your neurologists are eligible to apply for this program which unfortunately take us away from clinic for two days) and we get a half-day of... Read more
I just returned from an MS Town Hall Meeting. For the past year we have been holding these evening get-togethers to talk about the issues facing MS patients, carepartners and healthcare providers. There are no powerpoint or computer presentations, instead we use a flip-chart and markers. Since this is an online community, I want to... Read more